C07F 9/02
Phosphorus compounds
Official title: Phosphorus compounds (sugar phosphates C07H11/04; nucleotides C07H19/00, C07H21/00; nucleic acids C07H21/00)
C07F9/02 (Phosphorus compounds) appears on 17,649 US grants and 11,915 published applications in this corpus.
Search patents in C07F- Granted patents
- 17,649
- Published applications
- 11,915
- Assignees
- 4,807
- Inventors
- 32,397
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 582 | 0 |
| 1977 | 455 | 0 |
| 1978 | 612 | 0 |
| 1979 | 334 | 0 |
| 1980 | 356 | 0 |
| 1981 | 420 | 0 |
| 1982 | 264 | 0 |
| 1983 | 279 | 0 |
| 1984 | 329 | 0 |
| 1985 | 343 | 0 |
| 1986 | 259 | 0 |
| 1987 | 306 | 0 |
| 1988 | 277 | 0 |
| 1989 | 278 | 0 |
| 1990 | 277 | 0 |
| 1991 | 306 | 0 |
| 1992 | 318 | 0 |
| 1993 | 349 | 0 |
| 1994 | 316 | 0 |
| 1995 | 315 | 0 |
| 1996 | 339 | 0 |
| 1997 | 405 | 0 |
| 1998 | 432 | 0 |
| 1999 | 357 | 0 |
| 2000 | 322 | 0 |
| 2001 | 334 | 78 |
| 2002 | 341 | 330 |
| 2003 | 332 | 378 |
| 2004 | 251 | 454 |
| 2005 | 208 | 441 |
| 2006 | 278 | 435 |
| 2007 | 241 | 383 |
| 2008 | 262 | 390 |
| 2009 | 275 | 447 |
| 2010 | 311 | 462 |
| 2011 | 294 | 460 |
| 2012 | 343 | 436 |
| 2013 | 388 | 481 |
| 2014 | 418 | 555 |
| 2015 | 486 | 549 |
| 2016 | 432 | 559 |
| 2017 | 424 | 529 |
| 2018 | 449 | 573 |
| 2019 | 478 | 539 |
| 2020 | 426 | 472 |
| 2021 | 357 | 474 |
| 2022 | 308 | 510 |
| 2023 | 312 | 563 |
| 2024 | 323 | 539 |
| 2025 | 329 | 497 |
| 2026 | 219 | 381 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Biosynthesis of chemically diversified non-natural terpene products6 Oct 2026US 12,753,423 B2Board of Trustees of Michigan State University
- Polyhydroxylated cyclopentane derivatives and methods of use29 Sep 2026US 12,747,257 B2Sanegene Bio USA Inc.
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Substituted pyrimidinedione compounds, compositions, and uses thereof8 Oct 2026US 2026/0308184 A1Lakewood Amedex, Inc.
- Stat degraders and uses thereof8 Oct 2026US 2026/0308185 A1Recludix Pharma, Inc.
- Stat degraders and uses thereof8 Oct 2026US 2026/0308186 A1Recludix Pharma, Inc.
Most cited
By later US patents
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Synthetic phosphatidyl cholines useful in forming liposomes664US 4,485,045 AResearch Corporation · 1984
- Bead linkers for immobilizing nucleic acids to solid supports600US 5,900,481 ASequenom, Inc. · 1999
- Oligonucleotides with selectably cleavable and/or abasic sites574US 5,367,066 AChiron Corporation · 1994